NES
PPH icon

New England Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History

New England Securities’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$61K Buy
947
+50
+6% +$3.19K 0.02% 546
2014
Q3 		$57K Buy
897
+181
+25% +$11.2K 0.02% 576
2014
Q2 		$44K Sell
716
-192
-21% -$11.4K 0.02% 650
2014
Q1 		$53K Buy
908
+385
+74% +$21.8K 0.02% 543
2013
Q4 		$28K Buy
+523
New +$26.5K 0.01% 719

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

New England Securities's PPH Position: Q4 2014 in Review

New England Securities increased its VanEck Pharmaceutical ETF (PPH) stake by 5.6% in Q4 2014, buying an estimated $3.19K and bringing the position to 947 shares worth $61K. The position accounts for 0.02% of the portfolio, ranked #546.

New England Securities first reported a position in PPH in Q4 2013 and has held it in 5 quarters since. 58 funds tracked by Wall St. Rank hold PPH as of Q4 2014.

  • New England Securities held 947 shares of VanEck Pharmaceutical ETF worth $61K as of Q4 2014.
  • New England Securities bought 50 VanEck Pharmaceutical ETF shares in Q4 2014, an estimated $3.19K.
  • VanEck Pharmaceutical ETF made up 0.02% of New England Securities's portfolio in Q4 2014, its #546 holding.
  • New England Securities first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and has held it in 5 quarters since.
  • 58 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.